SIBN Stock Analysis: Buy, Sell, or Hold?
SIBN - SI-BONE, Inc. Common Stock
$16.58
0.03 (0.18%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 23, 2026
21d
Get Alerted When SIBN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SIBN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SIBN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SIBN is currently trading at $16.58, which is considered oversold relative to its 30-day fair value range of $16.86 to $20.15.
Technical Outlook: Technically, SIBN is in a strong uptrend. Immediate support is located at $16.07, while resistance sits at $17.56.
Market Sentiment: SIBN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $25.40 (+53.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SIBN is in a strong uptrend. Immediate support is located at $16.07, while resistance sits at $17.56.
Market Sentiment: SIBN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $25.40 (+53.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$16.86 -
$20.15
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.2% below Wall St target ($25.40)
Fair Price Analysis
30-Day Fair Range
$16.86 -
$20.15
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.09
(6.6%)
Support & Resistance Levels
Support Level
$16.07
Resistance Level
$17.56
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-33.61
Wall Street Target
$25.40
(+53.2%)
Revenue Growth (YoY)
20.6%
Profit Margin
-11.2%
Last updated: February 01, 2026 4:50 PM ET
Data refreshes hourly during market hours. Next update: 5:50 PM
Data refreshes hourly during market hours. Next update: 5:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SIBN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Anthony J Recupero
SELL
3311 shares
2025-10-02
Anshul Maheshwari
SELL
3311 shares
2025-10-02
Michael A Pisetsky
SELL
3128 shares
2025-10-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 68 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 54 HOLD |
